July 22 (Reuters) - Phytanix Bio and Chain Bridge I ( CBRG ):

* CHAIN BRIDGE I TO ACQUIRE PHYTANIX BIO, CREATING A NEW

PUBLIC

COMPANY FOCUSED ON DEVELOPING NEXT GENERATION CANNABINOID AND

CANNABINOID-LIKE MEDICINES

* CHAIN BRIDGE I ( CBRG ): TRANSACTION REFLECTS A PRE-DEAL VALUATION

OF $58

MILLION FOR PHYTANIX BIO

* CHAIN BRIDGE I ( CBRG ) - COMBINED COMPANY TO BE LISTED ON NASDAQ

CAPITAL

MARKETS UNDER TICKER "PHYX"

* CHAIN BRIDGE I ( CBRG ) - BARRETT EVANS WILL SERVE AS CEO OF

COMBINED

COMPANY

* CHAIN BRIDGE I ( CBRG ): NEW COMPANY WILL BE LED BY PHYTANIX BIO'S

FOUNDERS COLIN STOTT, DOMINIC SCHILLER AND BARRETT EVANS

* CHAIN BRIDGE I ( CBRG ): BUSINESS COMBINATION IS NOT SUBJECT TO A

MINIMUM

CASH CONDITION

Source text for Eikon:

Further company coverage: